Schrödinger

We're baking something exciting for the world of molecular visualization. Check back on Friday for a cutting-edge treat, dropping on Pi Day.

Schrödinger is pleased to announce the appointment of Bridget van Kralingen to our Board of Directors. Read the press release here: https://hubs.li/Q03b38M90

Are you attending the NextGen Biomed Conference in London, United Kingdom? Stop by booth 48 to speak with Schrödinger scientists and join our workshop on March 12, 12:05 PM GMT titled "Accelerating Biologics Design through Computational Modeling and Collaborative Enterprise Informatics.” Explore our solutions for biologics: https://lnkd.in/eYZVCfCR

Register now for Schrödinger's European User Group Meeting on June 3-5, 2025 in Budapest, Hungary. This in-person event will convene Schrödinger team members and customers from across Europe. The interactive program includes scientific presentations, workshops, and panel discussions, as well as networking opportunities and evening social events. Learn more and register: https://hubs.li/Q039qdmZ0

Today Schrödinger announced that we have expanded our research collaboration with Eli Lilly and Company with the addition of another undisclosed target, building on the previously announced collaboration. Learn more about the collaboration and additional company updates in our fourth quarter and full-year 2024 financial results press release: https://hubs.li/Q038tbjF0 Listen to the LIVE webcast at 4:30PM today for an update on our progress: https://hubs.li/Q038tLxN0

Schrödinger will announce fourth quarter and full-year 2024 financial results today. Join us at 4:30PM ET for an update on our progress. Listen to the LIVE webcast here: https://hubs.li/Q038jgmr0

Computational methods are revolutionizing drug discovery and becoming indispensable tools in the medicinal chemist's arsenal. In this Drug Hunter Flash Talk, Schrödinger's Aleksey Gerasyuto will discuss the application of physics-based modeling to inform medicinal chemistry decisions across several drug discovery programs within our internal and collaborative portfolio. Join us for the talk on Thursday, February 27th at 11 AM EST to hear examples of how FEP+ has been employed for potency and selectivity modeling, enabling the efficient discovery and optimization of chemical matter. Register here: https://hubs.li/Q0381-vq0

We recently welcomed a new cohort of fellows from the Introducing Molecular Modeling Experiences to under-Represented StudEnts (IMMERSE) program, funded by the National Science Foundation (NSF). We are proud to host these five students from City University of New York (CUNY) institutions during a 16-week paid internship, where they will contribute to educational materials that empower users of our platform. Schrödinger is proud to support this program and is committed to expanding access to computational molecular modeling for underrepresented students to ensure diversity in STEM.

Join us on February 26th for an exclusive webinar with C&EN exploring how advanced cloud infrastructure has enabled a decade of breakthroughs in materials discovery across industries. Schrödinger’s Mat Halls will describe how advanced cloud infrastructure is transforming large-scale materials simulation, and how implementation of a cloud-based materials modeling platform can help organizations maximize the value of digital simulations. Register now: https://hubs.li/Q0377dYl0

We're excited to share that our manuscript, "In Silico Enabled Discovery of KAI-11101," was featured on the front cover of today's issue of Journal of Medicinal Chemistry. This cover illustrates our preclinical candidate, KAI-11101, a potent, selective, brain-penetrant DLK inhibitor. Harnessing the power of computational chemistry to enable our discovery efforts, we tackled a number of common medicinal chemistry challenges by integrating innovative in silico workflows, efficiently identifying a promising ligand with neuroprotective properties. Read the paper: https://hubs.ly/Q036FWk50 Learn more about this work in our webinar: https://hubs.ly/Q036FXZ20